NO168352C - Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-allen-alfa-amino-syrer - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-allen-alfa-amino-syrer

Info

Publication number
NO168352C
NO168352C NO843273A NO843273A NO168352C NO 168352 C NO168352 C NO 168352C NO 843273 A NO843273 A NO 843273A NO 843273 A NO843273 A NO 843273A NO 168352 C NO168352 C NO 168352C
Authority
NO
Norway
Prior art keywords
alfa
amino acids
allen
preparation
therapeutically active
Prior art date
Application number
NO843273A
Other languages
English (en)
Norwegian (no)
Other versions
NO168352B (no
NO843273L (no
Inventor
Alesander Krantz
Arlindo Lucas Castelhano
Original Assignee
Syntes Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntes Usa Inc filed Critical Syntes Usa Inc
Publication of NO843273L publication Critical patent/NO843273L/no
Publication of NO168352B publication Critical patent/NO168352B/no
Publication of NO168352C publication Critical patent/NO168352C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
NO843273A 1983-08-17 1984-08-16 Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-allen-alfa-amino-syrer NO168352C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52447683A 1983-08-17 1983-08-17

Publications (3)

Publication Number Publication Date
NO843273L NO843273L (no) 1985-02-18
NO168352B NO168352B (no) 1991-11-04
NO168352C true NO168352C (no) 1992-02-12

Family

ID=24089362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843273A NO168352C (no) 1983-08-17 1984-08-16 Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-allen-alfa-amino-syrer

Country Status (15)

Country Link
EP (1) EP0134561B1 (de)
JP (1) JPS6089459A (de)
KR (1) KR900001182B1 (de)
AT (1) ATE28186T1 (de)
AU (1) AU571559B2 (de)
CA (1) CA1242203A (de)
DE (1) DE3464599D1 (de)
DK (1) DK394284A (de)
ES (3) ES8601853A1 (de)
FI (1) FI843245A7 (de)
HU (1) HU194808B (de)
IL (1) IL72703A (de)
NO (1) NO168352C (de)
NZ (1) NZ209250A (de)
ZA (1) ZA846388B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3075809U (ja) * 2000-08-23 2001-03-06 新世代株式会社 カラオケ用マイク

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT319993B (de) * 1971-07-14 1975-01-27 Plasser Bahnbaumasch Franz Fahrbare Gleisnivellier-Stopfmaschine
US3855271A (en) * 1973-12-20 1974-12-17 Lilly Co Eli 2-amino-2-allenylmalonic esters
US4178463A (en) * 1978-01-30 1979-12-11 Merrell Toraude Et Compagnie Process for making 4-aminohex-5-enoic acid
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative

Also Published As

Publication number Publication date
KR850001900A (ko) 1985-04-10
ATE28186T1 (de) 1987-07-15
HU194808B (en) 1988-03-28
KR900001182B1 (ko) 1990-02-27
DE3464599D1 (de) 1987-08-13
ES535188A0 (es) 1985-12-01
FI843245A0 (fi) 1984-08-16
ES8601853A1 (es) 1985-12-01
CA1242203A (en) 1988-09-20
IL72703A0 (en) 1984-11-30
NZ209250A (en) 1988-11-29
FI843245A7 (fi) 1985-02-18
ES545497A0 (es) 1986-12-01
AU571559B2 (en) 1988-04-21
JPS6089459A (ja) 1985-05-20
ES8701149A1 (es) 1986-12-01
DK394284D0 (da) 1984-08-16
EP0134561B1 (de) 1987-07-08
HUT34950A (en) 1985-05-28
ES545496A0 (es) 1987-01-16
AU3200584A (en) 1985-02-21
NO168352B (no) 1991-11-04
ZA846388B (en) 1986-03-26
EP0134561A1 (de) 1985-03-20
IL72703A (en) 1988-11-15
DK394284A (da) 1985-02-18
NO843273L (no) 1985-02-18
ES8702338A1 (es) 1987-01-16

Similar Documents

Publication Publication Date Title
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO162560C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolin- og benzoksazin-karboksylsyrer.
NO166232C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansyrer.
NO163857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO870240D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
FI925787A0 (fi) Proteolytiska enzymers sackarinderivatinhibitorer
NO854965L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pteridin-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO159929C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-substituerte 2-pyridylindoler.
NO158948C (no) Fremgangsmaate for fremstilling av enzymet kolesterase.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO168352C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-allen-alfa-amino-syrer
IT8520090A0 (it) Procedimento di purificazione di un enzima.
ES533079A0 (es) Procedimiento para la determinacion cuantitativa de la enzima c1 esterasa.
NO160712C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-forbindelser.
NO166322C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater.
NO162964C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridinderivater.
NO162285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.